These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22245483)

  • 21. Natural and synthetic biomaterials for controlled drug delivery.
    Kim JK; Kim HJ; Chung JY; Lee JH; Young SB; Kim YH
    Arch Pharm Res; 2014 Jan; 37(1):60-8. PubMed ID: 24197492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research on intelligent controlled drug delivery with polymer].
    Zhang Z; Tang C; Chen H; Shan L; Wan C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):205-8, 224. PubMed ID: 16532842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(2-ethyl-2-oxazoline) as matrix excipient for drug formulation by hot melt extrusion and injection molding.
    Claeys B; Vervaeck A; Vervaet C; Remon JP; Hoogenboom R; De Geest BG
    Macromol Rapid Commun; 2012 Oct; 33(19):1701-7. PubMed ID: 22893256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Film coatings for oral pulsatile release.
    Maroni A; Zema L; Loreti G; Palugan L; Gazzaniga A
    Int J Pharm; 2013 Dec; 457(2):362-71. PubMed ID: 23506956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solvent induced phase inversion-based in situ forming controlled release drug delivery implants.
    Thakur RR; McMillan HL; Jones DS
    J Control Release; 2014 Feb; 176():8-23. PubMed ID: 24374003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An investigation into silk fibroin conformation in composite materials intended for drug delivery.
    Cilurzo F; Gennari CG; Selmin F; Marotta LA; Minghetti P; Montanari L
    Int J Pharm; 2011 Jul; 414(1-2):218-24. PubMed ID: 21601621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extrudable core system: development of a single-layer osmotic controlled-release tablet.
    Waterman KC; MacDonald BC; Roy MC
    J Control Release; 2009 Mar; 134(3):201-6. PubMed ID: 19100796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of hot-melt extrusion for drug delivery.
    Repka MA; Majumdar S; Kumar Battu S; Srirangam R; Upadhye SB
    Expert Opin Drug Deliv; 2008 Dec; 5(12):1357-76. PubMed ID: 19040397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of burst release from pH-responsive polymeric microparticles.
    Rizi K; Green RJ; Khutoryanskaya O; Donaldson M; Williams AC
    J Pharm Pharmacol; 2011 Sep; 63(9):1141-55. PubMed ID: 21827486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tailor-made release triggering from hot-melt extruded complexes of basic polyelectrolyte and poorly water-soluble drugs.
    Kindermann C; Matthée K; Strohmeyer J; Sievert F; Breitkreutz J
    Eur J Pharm Biopharm; 2011 Oct; 79(2):372-81. PubMed ID: 21596136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled release formulation of ranitidine-containing montmorillonite and Eudragit E-100.
    Joshi GV; Kevadiya BD; Bajaj HC
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1046-53. PubMed ID: 20545505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and in-vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique.
    Li S; Liu Y; Liu T; Zhao L; Zhao J; Feng N
    Int J Pharm; 2011 Jun; 411(1-2):172-7. PubMed ID: 21511016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ forming parenteral drug delivery systems: an overview.
    Packhaeuser CB; Schnieders J; Oster CG; Kissel T
    Eur J Pharm Biopharm; 2004 Sep; 58(2):445-55. PubMed ID: 15296966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral pulsatile delivery systems based on swellable hydrophilic polymers.
    Gazzaniga A; Palugan L; Foppoli A; Sangalli ME
    Eur J Pharm Biopharm; 2008 Jan; 68(1):11-8. PubMed ID: 17888641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral controlled release dosage forms. II. Glassy polymers in hydrophilic matrices.
    Veiga F; Salsa T; Pina ME
    Drug Dev Ind Pharm; 1998 Jan; 24(1):1-9. PubMed ID: 15605591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug release characteristics from nanoclay hybrids and their dispersions in organic polymers.
    Ha JU; Xanthos M
    Int J Pharm; 2011 Jul; 414(1-2):321-31. PubMed ID: 21601624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in solid dosage form manufacturing technology.
    Andrews GP
    Philos Trans A Math Phys Eng Sci; 2007 Dec; 365(1861):2935-49. PubMed ID: 17855217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nano and microparticles as controlled drug delivery devices.
    Ravi Kumar MN
    J Pharm Pharm Sci; 2000; 3(2):234-58. PubMed ID: 10994037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basics of Compounding: Compounding Films.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):298-305. PubMed ID: 28333675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current advances in sustained-release systems for parenteral drug delivery.
    Shi Y; Li LC
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1039-58. PubMed ID: 16296808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.